跳至主要内容
临床试验/NCT02633813
NCT02633813已完成3 期

A Randomized, Prospective Multicenter, Double Blind, Parallel Assignment Placebo Controlled BE Study Of Naftifine Hydrochloride 2% Topical Cream With Naftin® In Patients With Tinea Pedis Using Clinical Endpoints

Genzum Life Sciences13 个研究点 分布在 2 个国家目标入组 693 人开始时间: 2015年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
693
试验地点
13
主要终点
Mycological cure and clinical cure for a single target lesion for Trichyphyton rubrum

研究概览

简要总结

The current study was randomized, double blind, placebo-controlled, prospective, multicenter, comparative therapeutic equivalence study.

The study duration for each patient was 6 weeks: Following were the visit details.

V1-Baseline and Randomization Visit (Day 1). V2- End of therapy visit (at the end of week 2 + 2 days). V3- Follow up visit (at the end of week 4 + 2 days). V4 - Test of cure visit ( at the end of week 6 + 4 days).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy males and females aged more than or equal to 18 years
  • Clinical diagnosis of tinea pedis with lesions localized to the interdigital spaces or predominantly interdigital, but may extend to other areas of the foot (the non-interdigital lesions should not be hyperkeratotic, i.e., characteristic of tinea pedis moccasin), and provisionally confirmed at baseline by a positive potassium hydroxide (KOH) wet mount preparation (i.e., skin scrapings from the target site are placed on a microscope slide with a drop of 10% KOH, and microscopic examination reveals segmented fungal hyphae)
  • The sum of the clinical signs and symptoms scores of the target lesion is at least 4, including a minimum score of at least 2 for erythema AND a minimum score of 2 for either scaling or pruritus (on a scale of 0-3, where 2 indicates moderate severity)

排除标准

  • Pregnant or lactating or planning to become pregnant during the study period
  • Use of antipruritics, including antihistamines, within 72 hours prior to entry into the study
  • Use of topical corticosteroid, antibiotics or antifungal therapy within 2 weeks prior to entry into the study
  • Use of systemic (e.g., oral or injectable) corticosteroid, antibiotics or antifungal therapy within 1 month prior to entry into the study
  • Use of oral terbinafine or itraconazole within 2 months prior to entry into the study
  • Use of immunosuppressive medication or radiation therapy within 3 months prior to entry into the study.
  • Confluent, diffuse moccasin-type tinea pedis of the entire plantar surface.
  • Presence of any other infection of the foot or other disease process that might confound the treatment evaluation
  • History of dermatophyte infections unresponsive to systemic or topical antifungal drugs
  • Known hypersensitivity to Naftifine Hydrochloride or to any component of the formulation

研究组 & 干预措施

Naftifine hydrochloride 2%

Experimental

A thin layer of sufficient quantity of Naftifine hydrochloride cream need to be applied to the affected areas plus an approximate ½ inch margin of healthy surrounding skin once daily consecutively for 2 weeks.

干预措施: Naftifine hydrochloride 2% (Drug)

Naftin® 2% (Naftifine hydrochloride 2%)

Active Comparator

A thin layer of sufficient quantity of Naftifine hydrochloride cream need to be applied to the affected areas plus an approximate ½ inch margin of healthy surrounding skin once daily consecutively for 2 weeks.

干预措施: Naftin® 2% (Naftifine hydrochloride 2%) (Drug)

Placebo vehicle cream.

Placebo Comparator

A thin layer of sufficient quantity of vehicle cream need to be applied to the affected areas plus an approximate ½ inch margin of healthy surrounding skin once daily consecutively for 2 weeks.

干预措施: Placebo (Drug)

结局指标

主要结局

Mycological cure and clinical cure for a single target lesion for Trichyphyton rubrum

时间窗: week 6 + 4 days

After 6 weeks the skin scrapping will be collected for culture to find out the growth of T rubrum. Absence of growth suggests complete cure.

次要结局

  • Mycological cure and clinical cure for Trichophyton rubrum, Trichophyton mentagrophytes, or Epidermophyton floccosum(week 6 + 4 days)

研究者

发起方
Genzum Life Sciences
申办方类型
Industry
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验